Home » and Pathways Monitoring

Related Case Studies

A First of its Kind Approval Changes the Way We Think About Access

A clinical-stage pharmaceutical company faced a unique barrier in bringing its first product to market—seeking pan-tumor approval based on a genetic marker, rather than a traditional approval based on cancer type. They subsequently sought recognition for the product across relevant clinical compendia.

View All Case Studies